Vancomycin pharmacokinetics in normal and morbidly obese subjects

scientific article published on April 1982

Vancomycin pharmacokinetics in normal and morbidly obese subjects is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1128/AAC.21.4.575
P932PMC publication ID181944
P698PubMed publication ID7081978

P2093author name stringMiller DD
Griffen WO Jr
Bauer LA
Blouin RA
Record KE
P2860cites workVancomycinQ34420845
The Sizes and Numbers of Cells in Visceral Organs in Human ObesityQ48905927
Tobramycin pharmacokinetics in morbidly obese patientsQ66940725
Theophylline disposition in obesityQ67289523
A controlled investigation of the pharmacokinetics of gentamicin and tobramycin in obese subjectsQ67404922
Estimating creatinine clearance in morbidity obese patientsQ70815669
Amikacin pharmacokinetics in morbidly obese patientsQ71202599
Single-dose kinetics of intravenous vancomycinQ71213813
Theophylline clearance: effect of marked obesityQ71395554
Assessment of Pharmacokinetic Constants from Postinfusion Blood Curves Obtained after I.V. InfusionQ71409547
Vancomycin Therapy in Patients with Impaired Renal Function: A Nomogram for DosageQ72417776
Vancomycin; clinical and laboratory studiesQ74483458
Blood volume, cardiac output, and distribution of systemic blood flow in extreme obesityQ76431236
Antibiotic therapy of bacterial endocarditis. VII. Vancomycin for acute micrococcal endocarditis; preliminary reportQ77167132
Anaphylactoid reaction to vancomycinQ78890130
Estimation of body surface area of extremely obese human subjectsQ79087076
P433issue4
P407language of work or nameEnglishQ1860
P921main subjectpharmacokineticsQ323936
obesityQ12174
vancomycinQ424027
P1104number of pages6
P304page(s)575-580
P577publication date1982-04-01
P1433published inAntimicrobial Agents and ChemotherapyQ578004
P1476titleVancomycin pharmacokinetics in normal and morbidly obese subjects
P478volume21